Criteria for Accepting Donors for Organ Transplantation with Proven or Suspected Infection

The microbiological screening of donated organs to avoid the transmission of pathogenic or potentially pathogenic micro-organisms is one of the main problems related to organ donor evaluation prior to transplantation (1-5). The Food and Drug Administration of the United States (FDA) (6) and the European Committee of Health (CDSP) (7) exclude as donors of tissues those who are at risk or are infected by human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV). However, with respect to organ donors, the recommendations are not sufficiently clear.